Relationship between subjective and actigraphy-measured sleep in 237 patients with metastatic colorectal cancer
Authors:
- 27 June 2017
- journal article
- research article
- Published by Springer Nature in Quality of Life Research
- Vol. 26 (10) , 2783-2791
Abstract
Objective Patients with cancers frequently experience sleep and circadian dysfunction. To date, only a few studies have used both a questionnaire and actigraphy for concomitant evaluation of sleep and circadian function in patients with cancer. We sought to evaluate objective sleep and circadian parameters in metastatic colon cancer (MCC) patients and their associations with symptoms and quality of life (QOL). Methods Patients reported subjective sleep problems on the EORTC QLQ-C30. Sleep and circadian parameters were calculated using a wrist-actigraph that patients wore for 72 h. Results 237 Patients with MCC (mean age: 60.4 years; range: 20.7–77.6; Male/Female ratio: 1.66) participated in this cross-sectional study. Subjective sleep problems were reported by 63.4% of patients (S+). No differences in any sleep parameters (sleep efficiency, sleep latency, total sleep time, total time in bed, wake after sleep onset, activity bathyphase) were observed between S+ and S− patients. However, S+ patients displayed a significantly worse circadian function than S− patients (96.4 vs 98.1%; p = 0.005). The presence of poor subjective sleep and objective circadian dysfunction negatively affected symptoms and QOL domains (p = 0.038). Conclusions Subjective report of sleep problems was not associated with worse objectively measured sleep parameters in patients with MCC although it was associated with disrupted circadian rest-activity rhythm and poorer QOL. These findings coincide with prior research in cancer patients in that an inconsistent relationship exists between subjective and objective sleep measurements on some sleep domains. This study supports the value of coupled evaluation of self-reported and objective measures of sleep and circadian function in cancer patients.Keywords
Funding Information
- National Cancer Institute (NCI R01CA181659, NCI R21CA185678)
This publication has 40 references indexed in Scilit:
- Prevalence, putative mechanisms, and current management of sleep problems during chemotherapy for cancerNature and Science of Sleep, 2012
- Symptom Cluster Patterns During the First Year After Diagnosis with CancerJournal of Pain and Symptom Management, 2010
- Prevalence, Demographics, and Psychological Associations of Sleep Disruption in Patients With Cancer: University of Rochester Cancer Center–Community Clinical Oncology ProgramJournal of Clinical Oncology, 2010
- Circadian Disruption, Fatigue, and Anorexia Clustering in Advanced Cancer Patients: Implications for Innovative Therapeutic ApproachesIntegrative Cancer Therapies, 2009
- Circadian Rhythm in Rest and Activity: A Biological Correlate of Quality of Life and a Predictor of Survival in Patients with Metastatic Colorectal CancerCancer Research, 2009
- Neuroendocrine-Immune Mechanisms of Behavioral Comorbidities in Patients With CancerJournal of Clinical Oncology, 2008
- Values of Sleep/Wake, Activity/Rest, Circadian Rhythms, and Fatigue Prior to Adjuvant Breast Cancer ChemotherapyJournal of Pain and Symptom Management, 2007
- Coordination of circadian timing in mammalsNature, 2002
- Quality of life research within the EORTC—the EORTC QLQ-C30European Journal of Cancer, 2002
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993